Despite its having no medicines on the market, the 17-year-old company's cancer-fighting technology has attracted attention from large pharmaceuticals.
It has signed deals with Bayer (BAYRY), Sanofi-Aventis (SNY), AstraZeneca (AZN), Germany's Merck (MRK) and Boehringer, Bloomberg reports.